LINK weekly review: gains as Senate draft bill and CME futures strengthen regulatory outlook

Traders Union
All News
Crypto News
Chainlink gains 3.71% this week

Highlights

Bitwise’s Chainlink ETF (CLNK) launched on NYSE Arca on January 14, 2026 following SEC approval, marking a milestone for institutional adoption.
Chainlink network growth accelerated as whale accumulation intensified and new confidential compute features were deployed alongside global financial institution tokenization pilots.
U.S. Senate Banking Committee introduced a draft bill to classify LINK as a commodity under CFTC jurisdiction, and CME Group announced regulated Chainlink futures plans.

Institutional adoption and regulatory progress fuel investor interest this week

Institutional adoption advanced as Bitwise’s Chainlink ETF (CLNK) began trading on NYSE Arca on January 14, 2026, after receiving SEC approval. Regulatory momentum persisted with the U.S. Senate Banking Committee introducing a draft bill to classify LINK as a commodity under CFTC jurisdiction, and CME Group revealed plans for regulated Chainlink futures. Whale accumulation intensified and network growth continued, with Chainlink deploying new confidential compute features and expanding integration with global financial institutions through tokenization pilots.

Mixed signals and oversold momentum as downside bias lingers over the week

On the weekly chart, LINK’s price hovers between $12.93 and $14.40, showing moderate volatility and a neutral, choppy tone. The asset remains below its MA-20 and MA-50, supporting the persistence of bearish momentum, but it is just above the MA-200, which is likely to act as support; Ichimoku Kijun at $17.89 stands as a distant resistance. Weekly momentum is mixed: MACD remains on a sell signal, ADX registers weak trend strength, RSI and CCI reflect mild selling pressure, and BBP signals oversold conditions, suggesting potential for a stall or bounce if selling eases.

Further declines favored next week as upside breakout odds remain low

Over the next week, LINK is projected to trade in a range of $12.95 – $14.45. The probability of an upward move is low, with less than a 20% chance, making further declines the more likely scenario. The baseline forecast expects sideways drift within the established range; a decisive breakout above $14.45 would target higher resistance, while a drop below $12.95 would expose LINK to further downside risk and test long-term support.

Viktoras Karapetjanc, analyst at Traders Union, notes that Chainlink posted a healthy 3.71% gain this week, with fundamental catalysts supporting its longer-term growth. He highlights fresh institutional momentum from the launch of Bitwise’s Chainlink ETF and progress on the regulatory front, boosting sentiment among large holders and market participants. Despite price hovering below key moving averages, Karapetjanc sees the asset defending its MA-200, with oversold conditions hinting at possible upside if sellers ease. Macro and network developments support the view that the bearish phase may be nearing exhaustion. "I believe this week’s advances in institutional adoption and regulation set the stage for Chainlink to surprise to the upside if it holds support — further growth looks increasingly probable."

Previously it was noted that institutional demand rose for Chainlink amid the launch of new futures and ETFs, including the Bitwise Chainlink ETF and recent initiatives supporting enterprise adoption. Technical analysis at that time indicated that the expected price range is $12.50 to $14.50, with a sideways outlook favored by most long-term indicators.

Source of Data: LINK Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.